UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 203

Sortiert nach

Social and Emotional Impairment in Children and Adolescents with ADHD and the Impact on Quality of Life

Journal of adolescent health, 2010-03, Vol.46 (3), p.209-217

2010

Link zum Volltext

Verfügbarkeit prüfen

Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind, COMBO-DN study

Pain (Amsterdam), 2014-10, Vol.155 (10), p.2171

2014

Link zum Volltext

Verfügbarkeit prüfen

A Randomized Double-Blind Study of Atomoxetine Versus Placebo for Attention-Deficit/Hyperactivity Disorder Symptoms in Children With Autism Spectrum Disorder

Journal of the American Academy of Child and Adolescent Psychiatry, 2012-07, Vol.51 (7), p.733-741

2012

Link zum Volltext

Verfügbarkeit prüfen

New Nonparametric Approach for Baseline Covariate Adjustment for Two-Group Comparative Studies

Biometrics, 2008-12, Vol.64 (4), p.1110-1116

2008

Link zum Volltext

Verfügbarkeit prüfen

Leading beyond regulatory approval: Opportunities for statisticians to optimize evidence generation and impact clinical practice

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2023-11, Vol.22 (6), p.1135-1140

2023

Link zum Volltext

Verfügbarkeit prüfen

Hochschulen auf einen Blick: Ausg. 2018

2018

Link zum Volltext

Verfügbarkeit prüfen

Modeling Heterogeneity in Patients’ Preferences for Psoriasis Treatments in a Multicountry Study: A Comparison Between Random-Parameters Logit and Latent Class Approaches

PharmacoEconomics, 2020-06, Vol.38 (6), p.593-606

2020

Link zum Volltext

Verfügbarkeit prüfen

Use of antipsychotics and benzodiazepines in patients with psychiatric emergencies: results of an observational trial

BMC psychiatry, 2008-07, Vol.8 (1), p.61-61, Article 61

2008

Link zum Volltext

Verfügbarkeit prüfen

Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain

Pain (Amsterdam), 2013-12, Vol.154 (12), p.2616

2013

Link zum Volltext

Verfügbarkeit prüfen

Impact of Nb and Al content in arc evaporation targets on Ti1−x−yAlxNbyN coating properties

Journal of vacuum science & technology. A, Vacuum, surfaces, and films, 2024-05, Vol.42 (3)

2024

Link zum Volltext

Verfügbarkeit prüfen

Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and Attention Deficit/Hyperactivity Disorder core symptoms: Meta-analysis of five atomoxetine trials

Child and adolescent psychiatry and mental health, 2010-12, Vol.4 (1), p.30-30, Article 30

2010

Link zum Volltext

Verfügbarkeit prüfen

We need to talk – or do we? Geographic distance and the commercialization of technologies from public research

Research policy, 2013-03, Vol.42 (2), p.465-480

2013

Link zum Volltext

Verfügbarkeit prüfen

Multilevel network meta‐regression for population‐adjusted treatment comparisons

Journal of the Royal Statistical Society. Series A, Statistics in society, 2020-06, Vol.183 (3), p.1189-1210

2020

Link zum Volltext

Verfügbarkeit prüfen

Morning and evening behavior in children and adolescents treated with atomoxetine once daily for attention-deficit/hyperactivity disorder (ADHD): findings from two 24-week, open-label studies

Child and adolescent psychiatry and mental health, 2009-02, Vol.3 (1), p.5-5, Article 5

2009

Link zum Volltext

Verfügbarkeit prüfen

Change in the direct cost of treatment for children and adolescents with hyperkinetic disorder in Germany over a period of four years

Child and adolescent psychiatry and mental health, 2009-01, Vol.3 (1), p.3-3, Article 3

2009

Link zum Volltext

Verfügbarkeit prüfen

Depression Treatment with Duloxetine and Reduction of Inability to Work

Depression Research and Treatment, 2012-01, Vol.2012, p.264854-6

2012

Link zum Volltext

Verfügbarkeit prüfen

Global impression of perceived difficulties in children and adolescents with attention-deficit/hyperactivity disorder: reliability and validity of a new instrument assessing perceived difficulties from a patient, parent and physician perspective over the day

Child and adolescent psychiatry and mental health, 2008-05, Vol.2 (1), p.10-10, Article 10

2008

Link zum Volltext

Verfügbarkeit prüfen

Turning scientific results into market: Technology transfer and commercilization of inventions from public research

Schacht, Alexander

2012

Link zum Volltext

Verfügbarkeit prüfen

Follow the leader? How leadership behavior influences scientists' commercialization behavior (or not)

Economics of innovation and new technology, 2014-01, Vol.23 (2), p.134-160

2014

Link zum Volltext

Verfügbarkeit prüfen

Atomoxetine treatment and ADHD-related difficulties as assessed by adolescent patients, their parents and physicians

Child and adolescent psychiatry and mental health, 2009-08, Vol.3 (1), p.21-21, Article 21

2009

Link zum Volltext

Verfügbarkeit prüfen

Parahydrogen‐Induced Polarization of a Labeled, Cancer‐Targeting DNA Aptamer

Angewandte Chemie (International ed.), 2023-05, Vol.62 (22), p.e202300531-n/a

International ed. in English, 2023

Link zum Volltext

Verfügbarkeit prüfen

Treatment response for acute depression is not associated with number of previous episodes: Lack of evidence for a clinical staging model for major depressive disorder

Journal of affective disorders, 2013-09, Vol.150 (2), p.344-349

2013

Link zum Volltext

Verfügbarkeit prüfen

Depression symptom clusters and their predictive value for treatment outcomes: Results from an individual patient data meta-analysis of duloxetine trials

Journal of psychiatric research, 2014-06, Vol.53, p.54-61

2014

Link zum Volltext

Verfügbarkeit prüfen

Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia

The journal of clinical psychiatry, 2006-11, Vol.67 (11), p.1690

2006

Link zum Volltext

Verfügbarkeit prüfen

What matters most? Different stakeholder perspectives on estimands for an invented case study in COPD

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2020-07, Vol.19 (4), p.370-387

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 203

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(160)
Mit Volltextzugriff
(187)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(179)
Deutsch
(26)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(105)
Life Sciences & Biomedicine
(83)
Humans
(61)
Female
(45)
Male
(45)
Psychiatry
(39)
Biological And Medical Sciences
(26)
Medical Sciences
(22)
Middle Aged
(22)
Adult
(20)
Neurosciences & Neurology
(19)
Psychology. Psychoanalysis. Psychiatry
(19)
Psychopathology. Psychiatry
(18)
Child
(17)
Clinical Neurology
(17)
Knowledge Management
(17)
Quality Of Life
(17)
Technology
(17)
Treatment Outcome
(17)
Attention Deficit Disorder With Hyperactivity - Drug Therapy
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Social and Emotional Impairment in Children and Adolescents with ADHD and the Impact on Quality of Life

Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind, COMBO-DN study

A Randomized Double-Blind Study of Atomoxetine Versus Placebo for Attention-Deficit/Hyperactivity Disorder Symptoms in Children With Autism Spectrum Disorder

New Nonparametric Approach for Baseline Covariate Adjustment for Two-Group Comparative Studies

Leading beyond regulatory approval: Opportunities for statisticians to optimize evidence generation and impact clinical practice

Hochschulen auf einen Blick: Ausg. 2018

Modeling Heterogeneity in Patients’ Preferences for Psoriasis Treatments in a Multicountry Study: A Comparison Between Random-Parameters Logit and Latent Class Approaches

Use of antipsychotics and benzodiazepines in patients with psychiatric emergencies: results of an observational trial

Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain

Impact of Nb and Al content in arc evaporation targets on Ti1−x−yAlxNbyN coating properties

Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and Attention Deficit/Hyperactivity Disorder core symptoms: Meta-analysis of five atomoxetine trials

We need to talk – or do we? Geographic distance and the commercialization of technologies from public research

Multilevel network meta‐regression for population‐adjusted treatment comparisons

Morning and evening behavior in children and adolescents treated with atomoxetine once daily for attention-deficit/hyperactivity disorder (ADHD): findings from two 24-week, open-label studies

Change in the direct cost of treatment for children and adolescents with hyperkinetic disorder in Germany over a period of four years

Depression Treatment with Duloxetine and Reduction of Inability to Work

Global impression of perceived difficulties in children and adolescents with attention-deficit/hyperactivity disorder: reliability and validity of a new instrument assessing perceived difficulties from a patient, parent and physician perspective over the day

Turning scientific results into market: Technology transfer and commercilization of inventions from public research

Follow the leader? How leadership behavior influences scientists' commercialization behavior (or not)

Atomoxetine treatment and ADHD-related difficulties as assessed by adolescent patients, their parents and physicians

Parahydrogen‐Induced Polarization of a Labeled, Cancer‐Targeting DNA Aptamer

Treatment response for acute depression is not associated with number of previous episodes: Lack of evidence for a clinical staging model for major depressive disorder

Depression symptom clusters and their predictive value for treatment outcomes: Results from an individual patient data meta-analysis of duloxetine trials

Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia

What matters most? Different stakeholder perspectives on estimands for an invented case study in COPD

Suchergebnisse filtern